BridgeMD
New treatment option for Cognitive Impairment
Official title Psychological Treatment to Support the Consequences of Cognitive Impairment
ClinicalTrials.gov ID: NCT04356924
What this study is testing
- What it's testing
- The burden of cognitive impairment is severe, and often hinders affected people to act independently in daily life. Individuals in different stages of cognitive decline are frequently affected by existential distress and associated health issues (such as stress symptoms, anxiety, and depression), as well as social avoidance due to the unclear prognosis.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 75
You may be able to join if
- Criteria's for inclusion
- \< 75 years.
- SCD or MCI diagnosis. All cognitive MCI-subtypes are eligible.
- Mild to moderate psychological symptoms that are indicated to be related to the patient's CI. The psychological symptoms should affect the patients...
- Fluency in the Swedish language.
See the full eligibility criteria
- Criteria's for inclusion
- \< 75 years.
- SCD or MCI diagnosis. All cognitive MCI-subtypes are eligible.
- Mild to moderate psychological symptoms that are indicated to be related to the patient's CI. The psychological symptoms should affect the patients daily living and behavior, exemplified by avoidance behavior, social...
- Fluency in the Swedish language.
- The patients should have access to a mobile telephone to be able to receive reminders via Short Message Service (SMS).
- Signed informed consent.
- Criteria's for exclusion
- Dementia diagnosis and/or occurrence of serious illness and/or injury that requires immediate investigation or treatment of another type, or which is expected to worsen in the coming year (i.e., not including dementia)
- Severe psychiatric comorbidity (e.g., high suicide risk), and/or severe psychiatric disorder. This will be assessed in the MINI evaluation and during the clinical cognitive examination).
- Anti-depressant medication introduced or alterations in dosage \< 6 months ago (i.e., un-stable dose).
- Mini Mental State Examination (MMSE) score \< 26 and/or a Montreal Cognitive Assessment (MoCA) score \< 24.
- Stroke or head trauma \< 6 months ago.
- Substance abuse
The study team makes the final eligibility decision.
Where it's taking place
- Stockholm, Stockholm County, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Stockholm, Stockholm County, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.